An Integrated Approach to Apply Quantitative Systems Pharmacology Model of Diabetes in Early Phase of Diabetes Research

被引：0
|
作者：
Geiser, Jeanne S. [1 ]
Schneck, Karen B. [1 ]
Chien, Jenny Y. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
T-035
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [1] An Approach to Incorporating Variability into a Quantitative Systems Pharmacology Model for Diabetes
    Waterhouse, Timothy H.
    Leohr, Jennifer K.
    Geiser, Jeanne S.
    Heathman, Michael A.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S116 - S116
  • [2] Simulations of Dulaglutide Phase 3 Studies Using a Quantitative Systems Pharmacology Model of Diabetes
    Geiser, Jeanne
    Tham, Lai San
    Milicevic, Zvonko
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S101 - S101
  • [3] A Quantitative Systems Pharmacology Kidney Model of Diabetes Associated Renal Hyperfiltration and the Effects of SGLT Inhibitors
    Balazki, Pavel
    Schaller, Stephan
    Eissing, Thomas
    Lehr, Thorsten
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2018, 7 (12): : 788 - 797
  • [4] A QUANTITATIVE SYSTEMS PHARMACOLOGY KIDNEY MODEL OF DIABETES ASSOCIATED RENAL HYPERFILTRATION AND THE EFFECTS OF SGLT INHIBITORS.
    Balazki, P.
    Schaller, S.
    Eissing, T.
    Lehr, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S30 - S30
  • [5] A Quantitative Systems Pharmacology Model of Asthma
    Smirnov, Sergey
    Lebedeva, Galina
    Demin, Oleg
    Petukhova, Tatiana
    Cucurull-Sanchez, Lourdes
    Fairman, David
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S108 - S109
  • [6] An integrated quantitative systems pharmacology virtual population approach for calibration with oncology efficacy endpoints
    Braniff, Nathan
    Joshi, Tanvi
    Cassidy, Tyler
    Trogdon, Michael
    Kumar, Rukmini
    Poels, Kamrine
    Allen, Richard
    Musante, Cynthia J.
    Shtylla, Blerta
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2025, 14 (02): : 268 - 278
  • [7] The power of an integrated informatic and molecular approach to type 1 diabetes research
    Petrovsky, N
    Silva, D
    IMMUNOLOGY OF DIABETES III, 2004, 1037 : 216 - 224
  • [8] STAGED DIABETES MANAGEMENT - TOWARD AN INTEGRATED MODEL OF DIABETES CARE
    MAZZE, RS
    ETZWILER, DD
    STROCK, E
    PETERSON, K
    MCCLAVE, CR
    MESZAROS, JF
    LEIGH, C
    OWENS, LW
    DEEB, LC
    PETERSON, A
    KUMMER, M
    DIABETES CARE, 1994, 17 : 56 - 66
  • [9] ANTHC DIABETES: A MODEL FOR INTEGRATED DIABETES PREVENTION AND CARE IN ALASKA
    Ramp, D.
    Narayanan, M.
    Manderfeld, A.
    Thompson, J.
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2013, 72 : 349 - 350
  • [10] The Wollondilly Diabetes Programme: A developing model of Diabetes Integrated Care
    Simmons, David
    Jani, Rati
    Macmillan, Freya
    Derek-Smith, Kylie
    Pham, Anna
    Fernandes, Brunelle
    Zarora, Reetu
    Alexander, Rachel
    Khoo, Chee
    Dench, Ally
    INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2018, 18
12345